Item 5.02 중요

임원 변동

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On May 5, 2026, Charles River Laboratories International, Inc. (the “Company”) held its 2026 annual meeting of shareholders (the “Annual Meeting”). As further discussed below, at the Annual Meeting, the shareholders of the Company approved the Company’s 2026 Long-Term Incentive Plan (the “2026 Incentive Plan”). The Board of Directors of ...

Item 5.07

주주총회 안건

CRL 주주총회에서 12명의 이사 선임(찬성률 95% 이상), 경영진 보상 승인(찬성률 93.8%), 2026년 장기인센티브 계획 승인(찬성률 94.1%), 감사인 재임명 승인(찬성률 95.3%)이 모두 가결되었다.